CLDWWCalidi Biotherapeutics Inc.
Price Chart
Loading chart...
About Calidi Biotherapeutics Inc. (CLDWW)
Calidi Biotherapeutics Inc. (CLDWW) is a Biotechnology company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the Pink tier.
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi's off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. This dual approach can potentially treat, or even prevent, metastatic disease.
CLDWW key facts
- Ticker symbol
- CLDWW
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Diego, CA, United States
- Country of incorporation
- US
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 12/31
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with C
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Calidi Biotherapeutics Inc. (CLDWW) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Social Media
Business Details
Stock Details
Loading modules...